Innovation in Action
Real-world cases studies, outcomes, and success stories demonstrating how our technology is transforming cancer patient care.
Below are some of the patient case-studies:
Case Study 01
Patient Details
Female
74 yrs
Clinical Presentation
Ca Breast
pT2pNO HR+/ HER2–
Clinical History
Patient underwent surgery.
We advised ONCOTYPE Dx but patient was unaffording.
We needed to decided between adjuvant chemotherapy and hormonal therapy.
Test Result
4 CTCs were found with 1 CTC Cluster indicating highly aggressive disease.
Clinical Outcome
Given her age – it was difficult to tolerate chemo.
4# TC – hormonal therapy X 7.5 yrs
Case Study 02
Patient Details
Male
45 yrs
Clinical Presentation
CA rectum
Clinical History
NACT+RT – Sx- CT (delayed due to myelosuppression).
PET Scan and CTC test done at end of therapy.
Test Result
4 CTCs were found with 1 CTC Cluster indicating highly aggressive disease.
PET Scan confirmed multiple liver mets.
Clinical Outcome
Patient underwent surgery.
Patient was unaffording for chemo and expired shortly.
Case Study 03
Patient Details
Female
60 years
Clinical Presentation
CA Breast ER-/PR-/HER2 3+
Clinical History
Sx-L.MRM-pT2N0
CHEMO-6 #TCH +2 # Herceptin (no funds)- on f/u.
PET Scan and CTC test suggested.
Test Result
2 CTCs were found indicating residual disease.
PET Scan confirmed liver mets.
Clinical Outcome
Meta analysis by TMH suggests that 6 months Herceptin is equal to 12 months.
In this particular case, 6M of Herceptin was not enough as patient developed liver mets.
Case Study 04
Patient Details
Female
60 years
Clinical Presentation
CA Breast
Suspicious lung nodules on PET SCAN
Clinical History
Sx –RT.MRM- pT2N2MO
CHEMO- ACX 4- TH X4 – Herceptin x 17 doses
CTC test was done post surgery and post chemotherapy.
Test Result
2 CTCs were found Surgery.
0 CTCs were found post chemotherapy.
Clinical Outcome
After 17 cycles of Herceptin, since CTC and PET was normal, hence we stopped at 1 yr of therapy.
Case Study 05
Patient Details
Female
64 years
Clinical Presentation
Ca Ovary
Stage IIIC
Clinical History
NACT x 3 #pacli –Carbo - ICS – Adj chemo X 3 # Pacli – Carbo-On f/u
CTC test was suggested post treatment.
Test Result
1 CTC were found in CTC Cluster form indicating aggressive residual disease.
CA125 was within normal limits.
CT scan – local recurrence
Clinical Outcome
Patient was put on Oral Metronomic Chemotherapy (OMCT)
Case Study 06
Patient Details
Female
33 years
Clinical Presentation
Ca Ovary
Stage IIIC
Clinical History
Primary cytoreduction done 4 yrs back.
6 #CT – PACLI-CARBO, counselled but PARPi not available hence didn't go for germline testing.
Patient was monitored with CTC test.
Test Result
2 CTCs were found during monitoring which indicated recurrence • PET CT showed recurrence.
Clinical Outcome
Recurrence in liver, hence surgery repeated.
Lipodox –Carbo x 6 #. Patient was found to be BRCA+. Patient was put on Rucaparib (8 months).
CTC is 0 on follow up.
- Page 1
Early detection is half the battle won.
Book a Test
Simply book a Test online or over a phone call and schedule a visit by our registered phlebotomists.
Sample Collection
Upon booking the Test, one of our registered phlebotomists shall visit and collect 10 ml of patient’s blood sample.
Receive Report
A set of diagnostics will be run on the patient’s blood sample and the report shall be provided in 7 working days upon receipt of sample on site.